Lyme borreliosis in Belgium: a cost-of-illness analysis

Last updated on 3-1-2023 by Laurence Geebelen

Public Access


Peer reviewed scientific article



Background. Lyme borreliosis (LB) is the most common tick-borne disease in Europe and North America, yet its economic burden remains largely unknown. This study aimed to estimate the economic cost associated with the different clinical manifestations of LB in Belgium. Methods. An incidence approach and societal perspective were used to estimate the total cost-of-illness for LB in Belgium. Costs were calculated for patients with erythema migrans (EM) or disseminated/late LB, including patients who developed post-treatment Lyme disease syndrome (PTLDS). Direct medical, direct non-medical (…

Associated health topics:

QR code

QR code for this page URL